Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies

K H Anders1, Z Z Wang, M Kornfeld

  • 1Department of Pathology & Laboratory Medicine (Neuropathology), UCLA School of Medicine, Los Angeles, CA 90095-1732, USA.

Human Pathology
|December 31, 1997
PubMed

Insights

Giant cell arteritis (GCA) in patients with severe cerebral amyloid angiopathy (CAA) may be a foreign body response to amyloid proteins. This response can lead to vessel wall destruction and neurological damage, without specific gene mutations.

Area of Science:

  • Neuropathology
  • Vascular Biology
  • Immunohistochemistry

Background:

  • Giant cell arteritis (GCA) is characterized by vascular inflammation.
  • Cerebral amyloid angiopathy (CAA) involves amyloid deposition in cerebral vessels.

Purpose of the Study:

  • To investigate the relationship between GCA and severe CAA.
  • To explore the underlying mechanisms of GCA in the context of CAA.

Main Methods:

  • Histopathological examination of six patients with GCA and severe CAA.
  • Immunohistochemical staining for beta/A4 peptide, cystatin C, HAM56, and smooth muscle actin.
  • Ultrastructural studies.
  • DNA analysis for APP and cystatin C gene mutations.

Main Results:

  • Patients presented with cerebral hemorrhage or infarct, associated with Alzheimer's disease histology.
  • Vessels with CAA showed significant infiltration of inflammatory cells, including multinucleated giant cells (MNGC).
  • Beta/A4 peptide was found in vessel walls and MNGC cytoplasm, suggesting phagocytosis.
  • Medial destruction by amyloid was observed, with relative preservation of intimal cells.
  • No previously described mutations in APP or cystatin C genes were found.

Conclusions:

  • GCA in severe CAA likely represents a foreign body reaction to amyloid proteins.
  • This reaction can cause secondary destruction of the vessel wall.
  • The observed GCA is not explained by known mutations in APP or cystatin C genes.